United Therapeutics Corporation (UTH)
Market Closed
3 Jun, 20:00
XSTU 
€
472. 80
+10.1
+2.18%
€
- Market Cap
11.96 P/E Ratio
- Div Yield
90 Volume
24.04 Eps
€ 462.7
Previous Close Want to track UTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 6.89 | - |
| | | 7.24 | - |
| | | 7.31 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
UTH Earnings Reports FAQ
What is the earnings per share (EPS) for UTH?
The current EPS is 24.04.
What is the company's earnings growth rate?
United Therapeutics Corporation has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
United Therapeutics Corporation has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for United Therapeutics Corporation are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for UTH at this time, as United Therapeutics Corporation has no recent EPS data to calculate it.
